Chugai Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
8/10
|
13.49 | 31.37 | -57% | 18.78 | -28.15% |
| P/S |
|
3.95 | 3.24 | 21.76% |
|
|
| P/BV |
|
0.0192 | 3.11 | -99.38% |
|
|
| P/FCF |
|
0.1448 | 16.56 | -99.13% |
|
|
| Ev/Ebitda |
|
-130.58 | 10.14 | -1387.29% |
|
|
| Ev/S |
|
-52.54 | 1.93 | -2824.02% |
|
|
| Ev/FCF |
|
-1.23 | 14 | -108.77% |
|
|
| E/P |
|
0.0473 | 1.47 | -96.78% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
40.23 | 25.1 | 60.32% | 38.36 | +4.87% |
| ROE |
|
0.142 | 13.38 | -98.94% |
|
|
| ROA |
|
0.1195 | 6.25 | -98.09% |
|
|
| ROIC |
|
34.85 | 15.56 | 123.99% |
|
|
| ROS |
|
29.3 | 12.85 | 128.04% |
|
|
| ROCE |
|
0.1812 | 15.02 | -98.79% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
2/10
|
4.24 | 6.27 | -32.36% | 2.56 | +65.47% |
| Nеt Debt/Ebitda |
|
-140.4 | -5.74 | 2346.7% |
|
|
| Debt/Ratio |
|
0.007 | 0.2174 | -96.8% |
|
|
| Debt/Equity |
|
1.38 | 12.62 | -89.06% |
|
|
| Debt/Net Income |
|
5.83 | 15.13 | -61.5% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.56 | -100% | 1.91 | -100% |
| Number of years of dividend growth |
|
1 | 1.3 | -22.83% | ||
| DSI |
|
0.7143 | 0.7874 | -9.28% |
|
|
| Average dividend growth |
|
-1715.78 | -247.19 | 594.11% |
|
|
| Average percentage for 5 years |
|
1.91 | 2.81 | -31.88% |
|
|
| Average percentage for payments |
|
311.69 | 245.59 | 26.91% |
|
|
| Difference from average difference in sector |
|
-1.56 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-98.91 | 60.04 | -264.74% | ||
| Growth impulse Ebitda in 5 years |
|
-98.56 | 46.61 | -311.46% | ||
| Growth impulse Net Income in 5 years |
|
-98.6 | 52.94 | -286.25% | ||
| Growth impulse FCF in 5 years |
|
119.7 | 32.41 | 269.33% | ||
| Growth impulse EPS in 5 years |
|
-97.2 | 116.39 | -183.51% |
IP Score
4.37/10
